Market Closed

NRSN
NeuroSense Therapeutics Ltd.
$ 1.69
-3.98%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

NeuroSense Therapeutics Ltd. News

Latest NeuroSense Therapeutics Ltd. Stock News & NRSN Headlines

NeuroSense to Strengthen PrimeC Canadian ALS Submission With New NfL Data
13 days ago | prnewswire.com
NeuroSense to Present Integrated Clinical and Biomarker Evidence Shaping PrimeC's Phase 3 Development at NEALS 2026
17 days ago | prnewswire.com
NeuroSense Files U.S. Patent Application for Traumatic Brain Injury
a month ago | prnewswire.com
NeuroSense Secures Nasdaq Hearing Date as PrimeC Approaches Key Regulatory and Funding Milestones
a month ago | prnewswire.com
NeuroSense to Participate in the 5th Annual ROTH Healthcare Opportunities Conference
2 months ago | prnewswire.com
NeuroSense Provides Business Update and Progress for the First Half of 2026
2 months ago | prnewswire.com
NeuroSense Unveils Accelerated, Capital-Efficient Strategy to Advance PrimeC Toward Potential Approval in ALS
2 months ago | prnewswire.com
NeuroSense Issues CEO Letter to Shareholders
3 months ago | prnewswire.com
NeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada
3 months ago | gurufocus.com
NeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada
3 months ago | prnewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

NRSN
NeuroSense Therapeutics Ltd.
$ 1.69
-3.98%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago